Cargando…

Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone

INTRODUCTION: Physician-pharmacist collaborative practice models (PPCPM) decrease barriers and increase access to medications for opioid use disorder (MOUD) but are not routine in practice. The purpose of this quality improvement initiative is to develop and implement a PPCPM for management of patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mailloux, Lindsay M., Haas, Matthew T., Larew, Janel M., DeJongh, Beth M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	College of Psychiatric & Neurologic Pharmacists 2021
Materias:	Innovative Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800330/ https://www.ncbi.nlm.nih.gov/pubmed/33505825 http://dx.doi.org/10.9740/mhc.2021.01.035

Ejemplares similares

Description of a pharmacist-led clinical video telehealth group clinic for opioid overdose prevention and naloxone education
por: Jensen, Aimee N., et al.
Publicado: (2019)

Implementation and evaluation of depression screening in patients with recently diagnosed coronary artery disease
por: Mailloux, Lindsay M., et al.
Publicado: (2020)

Evaluation and optimization of take-home naloxone in an academic medical center
por: Cooler, Jordan, et al.
Publicado: (2019)

Implementation and evaluation of Parkinson disease management in an outpatient clinical pharmacist–run neurology telephone clinic
por: Stefan, Teodora Cristina, et al.
Publicado: (2018)

Mental health pharmacists as interim prescribers
por: Gibu, Matthew, et al.
Publicado: (2018)

Buprenorphine/naloxone addiction in a pharmacist as a result of migraine self-treatment
por: Norton, Merrill, et al.
Publicado: (2016)

Comparison of clozapine monitoring and adverse event management in a psychiatrist-only and a clinical pharmacist-psychiatrist collaborative clinic
por: Maryan, Samantha, et al.
Publicado: (2019)

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
por: McCormack, Lindsay, et al.
Publicado: (2021)

Impact of the addition of a clinical pharmacist to a community hospital psychiatric consult liaison team
por: Rainey, Carly A., et al.
Publicado: (2020)

Pharmacist-led telemental health transitions of care clinic improves antidepressant medication continuity posthospitalization
por: Barrett, Monica, et al.
Publicado: (2020)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Emergency physician perspectives on initiating buprenorphine/naloxone in the emergency department: A qualitative study
por: Dong, Kathryn A., et al.
Publicado: (2021)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Reconsidering the Usefulness of Adding Naloxone to Buprenorphine
por: Blazes, Christopher K., et al.
Publicado: (2020)

Impact on hospital-wide antipsychotic prescribing practices through physician peer comparison letters
por: Davis, Erica A. K.
Publicado: (2022)

Practical implementation of noninvasive ventilation in Amyotrophic Lateral Sclerosis: lessons learned from a clinical case series
por: Parsons, Elizabeth C., et al.
Publicado: (2019)

Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan
por: Goshgarian, Gregory, et al.
Publicado: (2022)

Disparities in Emergency Department Naloxone and Buprenorphine Initiation
por: Papp, Joan, et al.
Publicado: (2023)

Creation and implementation of a urinary tract infection diagnostic and treatment algorithm for psychiatric inpatients with a communication barrier
por: Rarrick, Christine, et al.
Publicado: (2020)

Michigan Pharmacists Transforming Care and Quality: Developing a Statewide Collaborative of Physician Organizations and Pharmacists to Improve Quality of Care and Reduce Costs
por: Choe, Hae Mi, et al.
Publicado: (2018)

Successful Management of Kratom Use Disorder With Buprenorphine and Naloxone
por: Arhin, Martin, et al.
Publicado: (2023)

Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone
por: Gawronski, Kristen M, et al.
Publicado: (2014)

A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
por: Simojoki, Kaarlo, et al.
Publicado: (2008)

Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone(®)) in Spain
por: Martinez-Raga, Jose, et al.
Publicado: (2012)

Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
por: Mauger, Sofie, et al.
Publicado: (2014)

Low-dose naloxone provides an abuse-deterrent effect to buprenorphine
por: Webster, Lynn R, et al.
Publicado: (2015)

Yoga as an Adjunctive Intervention to Medication-Assisted Treatment with Buprenorphine+Naloxone
por: Lander, Laura, et al.
Publicado: (2017)

Sexual dysfunction in men on buprenorphine – naloxone-based substitution therapy
por: Mattoo, Surendra K., et al.
Publicado: (2020)

Extended-release monthly buprenorphine injection
por: Cuperfain, Ari B., et al.
Publicado: (2023)

Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome
por: DeJongh, Beth M.
Publicado: (2021)

Developing a harmonized heat warning and information system for Ontario: a case study in collaboration
por: Henderson, Dave, et al.
Publicado: (2020)

The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
por: Hansen, Brenna, et al.
Publicado: (2022)

The Cognitive Daisy – A novel method for recognising the cognitive status of older adults in residential care: Innovative Practice
por: Hudson, John M, et al.
Publicado: (2016)

Comparison of Pharmacist and Physician Managed Annual Medicare Wellness Services
por: Sewell, Mary Jean, et al.
Publicado: (2016)

Facilitating recruitment for dementia research: Insights from an international panel
por: Tam, Mallorie T, et al.
Publicado: (2020)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
por: Lund, Ingunn O., et al.
Publicado: (2013)

Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment
por: Barry, Declan T., et al.
Publicado: (2007)

New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone
por: Soyka, Michael
Publicado: (2015)

Evaluation of drug-drug interaction between daclatasvir and methadone or buprenorphine/naloxone
por: Garimella, Tushar, et al.
Publicado: (2014)

Safety and Efficacy of Buprenorphine-Naloxone in Pregnancy: A Systematic Review of the Literature
por: Ordean, Alice, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kii1j2a2rsmqac4f2mhklkbp5e